CLASP II D: A randomized comparison of TEER devices for degenerative mitral regurgitation
Reported from TCT 2022
Luigi Biasco interviews Scott Lim and Konstantinos P. Koulogiannis, Principal Investigators of CLASP IID.
The trial demonstrated safety and effectiveness of the PASCAL system and met non-inferiority endpoints, expanding transcatheter treatment options for prohibitive surgical risk patients with significant symptomatic degenerative mitral regurgitation.
Authors
No comments yet!